Remission Realized: Achieving Disease Control in Your Patients with Rheumatoid Arthritis : Episode 1

Opinion

Video

August 8, 2024

Intro and Welcomes

Author(s):

Gordon Lam, MD,Leonard Calabrese, DO

A panel of medical experts introduce themselves before diving into a discussion about remission achievement in rheumatoid arthritis.

EP: 1.Intro and Welcomes

EP: 2.Evolving Goals in Rheumatoid Arthritis Treatment: Defining and Achieving Clinical Remission

EP: 3.Prevalence and Management of Poorly Controlled Rheumatoid Arthritis in Clinical Practice

EP: 4.Complications and Prognostic Factors in Uncontrolled Rheumatoid Arthritis

EP: 5.Evaluating and Adjusting Rheumatoid Arthritis Treatment: Adhering to ACR Guidelines for csDMARDs and Advanced Therapies

EP: 6.Exploring the Discrepancy Between Patient Perception and Disease Activity Assessments

EP: 7.Achieving Low Disease Activity and Remission: Managing Patient Expectations

EP: 8.Guidance on Transitioning from TNFi to Non-TNF Targeted Therapies

EP: 9.Advanced Treatment Options for RA: Exploring the Data

EP: 10.Guiding Treatment Decisions: The Role of Remission Data and Head-to-Head Comparisons

EP: 11.JAK Inhibitors vs TNF Inhibitors: Effects on Administration, Efficacy, and Safety

EP: 12.JAK Inhibitor Selectivity and Dose-Related Toxicity

EP: 13.Outcomes of Class Switching vs Cycling TNF Inhibitors

EP: 14.Cycling Within TNF Inhibitors: Complications and Factors Influencing Treatment Choices

EP: 15.Safety and Efficacy of Janus Kinase Inhibitors

EP: 16.Closing Remarks

Related Videos

Jennifer Flemming, MD | Credit: AASLD

3 experts are featured in this series.

John Kane, MD | Credit: Northwell Health

Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.